Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma

Supplementary Figure S4 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma

Authors:
  • JBJames Brugarolas
    James Brugarolas
  • GOGregory Obara
    Gregory Obara
  • KBKathryn E. Beckermann
    Kathryn E. Beckermann
  • BRBrian Rini
    Brian Rini
  • ELElaine T. Lam
    Elaine T. Lam
  • JHJames Hamilton
    James Hamilton
  • TSThomas Schluep
    Thomas Schluep
  • MYMin Yi
    Min Yi
  • SWSo Wong
    So Wong
  • ZMZhongping Lily Mao
    Zhongping Lily Mao
  • EGErick Gamelin
    Erick Gamelin
  • NTNizar M. Tannir
    Nizar M. Tannir

Open Access
Publisher website
Google Scholar
  • 3 June 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.25956245.v1
Abstract
Figure S4: Tumor Tissue Distribution of ARO-HIF2 Trigger
Keywords
  • BIOLOGICAL AGENTS & THERAPIES
  • GENE THERAPY
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • GENITOURINARY CANCERS
  • RENAL CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.